These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17682206)

  • 21. Dynamic contrast-enhanced breast MR imaging.
    Moon M; Cornfeld D; Weinreb J
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
    Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
    Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of dynamic contrast-enhanced MR mammography imaging in the diagnosis of breast tumors].
    Iakovleva EK; Tiutin LA; Tikhova KE; Pozdniakov AV; Shelkoplias EN
    Vopr Onkol; 2008; 54(4):445-51. PubMed ID: 18942398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M; Yasuhiro T; Murase K
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced magnetic resonance imaging and invasive breast cancer: primary lesion kinetics correlated with axillary lymph node extracapsular extension.
    Loiselle CR; Eby PR; Peacock S; Kim JN; Lehman CD
    J Magn Reson Imaging; 2011 Jan; 33(1):96-101. PubMed ID: 21182126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gradually enhancing breast cancer on dynamic MRI].
    Isomoto I; Koshiishi T; Okimoto T; Okada H; Uetani M; Hayashi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Aug; 60(9):514-9. PubMed ID: 11019579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exception to tumour neoangiogenesis in a malignant breast-lesion.
    Baltzer PA; Benndorf M; Gajda M; Kaiser WA
    Breast J; 2010; 16(2):197-8. PubMed ID: 20030653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scanner design assists MRI of the breast.
    Pugh PA; Burnett KR
    Diagn Imaging (San Franc); 1995 Oct; Suppl():MR7-9. PubMed ID: 10159847
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic breast MR imaging: current status and future directions.
    Morris EA
    Radiol Clin North Am; 2007 Sep; 45(5):863-80, vii. PubMed ID: 17888774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preoperative evaluation of pathologic response in patients with breast cancer by dynamic contrast-enhanced magnetic resonance imaging].
    Zhang XP; Li J; Sun YS; Cao K; Tang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):98-103. PubMed ID: 18361063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings.
    Kawashima H; Kobayashi-Yoshida M; Matsui O; Zen Y; Suzuki M; Inokuchi M
    J Magn Reson Imaging; 2010 Nov; 32(5):1117-23. PubMed ID: 21031517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of diagnosis technology for breast cancer].
    Gomi N
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2339-43. PubMed ID: 19117101
    [No Abstract]   [Full Text] [Related]  

  • 36. Paclitaxel in Breast Cancer: Putting the Evidence into Practice. Proceedings from the Pan European Interactive Forum. Lisbon, Portugal, June 28, 1997.
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):9-48. PubMed ID: 9516595
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular targets in breast cancer: current status and future directions.
    Cristofanilli M; Hortobagyi GN
    Endocr Relat Cancer; 2002 Dec; 9(4):249-66. PubMed ID: 12542402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer: new strategies to beat an old enemy.
    Workman ML
    Nursing; 2002 Oct; 32(10):58-63; quiz 63-4. PubMed ID: 12395045
    [No Abstract]   [Full Text] [Related]  

  • 39. Biomarker-led adaptive trial blazes a trail in breast cancer.
    Allison M
    Nat Biotechnol; 2010 May; 28(5):383-4. PubMed ID: 20458285
    [No Abstract]   [Full Text] [Related]  

  • 40. Delays in diagnosis in breast cancer.
    Crawford SM
    Lancet; 1999 Oct; 354(9188):1478. PubMed ID: 10543704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.